Faeth Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Faeth Therapeutics, Inc. (FTH) reported Diluted Shares Outstanding (Weighted Average) of 5.64 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-04
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 5.64M shares, a 347.57% increase year-over-year.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.30M shares, a 2.82% increase year-over-year.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 1.26M shares, a 0.25% increase year-over-year.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 1.26M shares, a 0.32% increase year-over-year.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.26M shares, a 0.40% increase from fiscal 2024.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.26M shares, a 95.51% decline from fiscal 2023.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 27.95M shares, a 8.96% decline from fiscal 2022.
- Faeth Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 30.70M shares, a 10.80% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.64M shares 10-Q · filed 2026-08-04 | 3.48M shares 10-Q · filed 2026-08-04 | 2.73M shares derived: average of 3 quarters · filed 2026-08-04 | 2.37M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | 1.30M shares 10-Q · filed 2026-05-15 | 1.28M shares derived: average of 2 quarters · filed 2026-05-15 | 1.27M shares derived: average of 3 quarters · filed 2026-05-15 | 1.27M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | 1.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.26M shares derived: average of 2 quarters · filed 2026-03-30 | 1.26M shares derived: average of 3 quarters · filed 2026-08-04 | 1.26M shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 1.26M shares 10-Q · filed 2025-11-14 | 1.26M shares derived: average of 2 quarters · filed 2026-08-04 | 1.26M shares 10-Q · filed 2025-11-14 | 1.26M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | 1.26M shares 10-Q · filed 2026-08-04 | 1.26M shares 10-Q · filed 2026-08-04 | 1.26M shares derived: average of 3 quarters · filed 2026-08-04 | 1.26M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | 1.26M shares 10-Q · filed 2026-05-15 | 25.19M shares 10-Q · filed 2025-05-06 | 1.26M shares derived: average of 2 quarters · filed 2026-05-15 | 1.26M shares derived: average of 3 quarters · filed 2026-05-15 | 1.26M shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | 1.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.26M shares derived: average of 2 quarters · filed 2026-03-30 | 1.26M shares derived: average of 3 quarters · filed 2026-03-30 | 1.26M shares 10-K · filed 2026-03-30 | 25.12M shares 10-K · filed 2025-03-28 | |||
| 2024-09-30 | 1.26M shares 10-Q · filed 2025-11-14 | 25.15M shares 10-Q · filed 2024-11-14 | 1.26M shares derived: average of 2 quarters · filed 2025-11-14 | 1.25M shares 10-Q · filed 2025-11-14 | 25.10M shares 10-Q · filed 2024-11-14 | 13.14M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 1.26M shares 10-Q · filed 2025-08-05 | 25.10M shares 10-Q · filed 2024-08-06 | 1.25M shares 10-Q · filed 2025-08-05 | 25.08M shares 10-Q · filed 2024-08-06 | 17.10M shares derived: average of 3 quarters · filed 2025-08-05 | 19.20M shares derived: average of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | 25.05M shares 10-Q · filed 2025-05-06 | 25.02M shares derived: average of 2 quarters · filed 2025-05-06 | 25.18M shares derived: average of 3 quarters · filed 2025-05-06 | 26.51M shares derived: average of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | 24.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 25.25M shares derived: average of 2 quarters · filed 2025-03-28 | 27.00M shares derived: average of 3 quarters · filed 2025-03-28 | 27.95M shares 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | 25.51M shares 10-Q · filed 2024-11-14 | 28.01M shares derived: average of 2 quarters · filed 2024-11-14 | 28.94M shares 10-Q · filed 2024-11-14 | 29.41M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 30.51M shares 10-Q · filed 2024-08-06 | 30.69M shares 10-Q · filed 2024-08-06 | 30.71M shares derived: average of 3 quarters · filed 2024-08-06 | 30.71M shares derived: average of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | 30.87M shares 10-Q · filed 2024-05-09 | 30.80M shares derived: average of 2 quarters · filed 2024-05-09 | 30.78M shares derived: average of 3 quarters · filed 2024-05-09 | 30.76M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 30.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 30.73M shares derived: average of 2 quarters · filed 2024-02-29 | 30.72M shares derived: average of 3 quarters · filed 2024-02-29 | 30.70M shares 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | 30.72M shares 10-Q · filed 2023-11-07 | 30.71M shares derived: average of 2 quarters · filed 2023-11-07 | 30.69M shares 10-Q · filed 2023-11-07 | 30.68M shares derived: average of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | 30.70M shares 10-Q · filed 2023-08-03 | 30.67M shares 10-Q · filed 2023-08-03 | 30.66M shares derived: average of 3 quarters · filed 2023-08-03 | 30.64M shares derived: average of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | 30.65M shares 10-Q · filed 2023-05-09 | 30.64M shares derived: average of 2 quarters · filed 2023-05-09 | 30.62M shares derived: average of 3 quarters · filed 2023-05-09 | |||||
| 2021-12-31 | 30.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 30.61M shares derived: average of 2 quarters · filed 2023-03-29 | 27.71M shares 10-K · filed 2023-03-29 | |||||
| 2021-09-30 | 30.59M shares 10-Q · filed 2022-11-08 | 26.74M shares 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |